Prevalence and the associated factors of hepatitis B and hepatitis C viral infections among HIV-positive individuals in same-day antiretroviral therapy initiation program in Bangkok, Thailand

• Egile Nagusiak: Supanat Thitipatarakorn (Egilea), Tanat Chinbunchorn (Egilea), Jitsupa Peelay (Egilea), Pich Seekaew (Egilea), Sorawit Amatavete (Egilea), Monsiri Sangsai (Egilea), Tippawan Pankam (Egilea), Anchalee Avihingsanon (Egilea), Matthew Avery (Egilea), Praphan Phanuphak (Egilea), Reshmie Ramautarsing (Egilea), Nittaya Phanuphak (Egilea)
• Formatua: Liburua
• Argitaratua: BMC, 2022-01-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract Background Viral hepatitis is highly prevalent among people with HIV (PWH) and can lead to chronic liver complications. Thailand started universal hepatitis B vaccination at birth in 1992 and achieved over 95% coverage in 1999. We explored the prevalence of hepatitis B and C viral infection...